Expense on Upgrade & Development of Product is Capital Expense

Bioplus Life Sciences Pvt. Ltd. Vs DCIT (Karnataka High Court)

The issue under consideration is whether the expenditure incurred towards upgraded and development of a product was to be considered as capital expenditure or revenue expenditure?

High Court states that when an expenditure is made, not only once and for all, but with a view to bringing into existence an asset or an advantage for the enduring benefit of trade, there is very good reason for treating such an expen

Please become a Premium member. If you are already a Premium member, login here to access the full content.